Table 3. Location of tumour, histopathology and type of procedure versus 5-year survival.
| Parameter | % of 5-year survival (%) | P |
|---|---|---|
| Tumour location | 0.3655 | |
| Lobe upper left | 9/28 (32.14) | |
| Lower left | 7/38 (18.42) | |
| Upper right and middle | 3/15 (20.00) | |
| Lower right | 4/29 (13.79) | |
| Histopathology | 0.5173 | |
| Adenocarcinoma | 11/57 (19.30) | |
| Squamous cell carcinoma | 11/42 (26.19) | |
| Large cell carcinoma | 1/11 (9.09) | |
| Type of procedure | 0.8271 | |
| Lobectomy | 13/61 (21.31) | |
| Bilobectomy | 3/10 (30.00) | |
| Pneumonectomy | 6/31 (19.35) | |
| Wedge resection | 1/8 (12.50) | |
| T feature | 0.0824 | |
| T1 | 10/29 (34.48) | |
| T2 | 12/65 (18.46) | |
| T3 | 1/14 (7.14) | |
| T4 | 0/2 (0) | |
| N1 feature/skip metastases | 0.25 | |
| Skip metastases | 8/23 (34.78) | |
| N1 | 15/71 (21.13) | |
| N2 feature | 0.01 | |
| 1 group N2 | 22 (20.0) | |
| 2 group N2 | 1 (0.9) | |
| 3 group N2 and more | 0 (0.0) |